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ABSTRACT
Effects of benzene and several pharmaceuticals on the growth and microcystin production in Microcystis aeruginosa
PCC 7806
Currently, the presence of several pharmaceuticals and other organic compounds called ‘emerging’ contaminants has increased
in water bodies. These compounds do not need to persist in the environment to cause negative effects because they are
continuously introduced. Hence, assessing the effects of these compounds on aquatic ecosystems is essential. Therefore,
the aim of the present study was to analyse the effects of several emerging contaminants (ibuprofen, atenolol, diclofenac
and paracetamol) and benzene on Microcystis aeruginosa PCC 7806 growth and toxicity. For this purpose, the growth and
intracellular microcystin concentration in M. aeruginosa PCC 7806 were measured in presence of the four emerging
contaminants and benzene. The growth rate was estimated by chlorophyll a concentration, and no relevant changes were
found. Changes in the expression of the operon mcy were examined by semi-quantitative RT-PCR. Intracellular microcystin
production was determined using a MicroCystest R⃝ kit, and no changes were observed compared to control cells. Thus, the
tested concentrations of the contaminants analysed in this study do not have a significant effect on microcystin production in
this strain under laboratory conditions.
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RESUMEN
Efecto del benceno y algunos fármacos en el crecimiento y producción de microcistina en Microcystis aeruginosa PCC
7806
El objetivo del presente estudio ha sido analizar el efecto del benceno y de algunos de los contaminantes emergentes
más abundantes como el ibuprofeno, atenolol, diclofenac y paracetamol sobre el crecimiento de una cianobacteria toxica,
Microcystis aeruginosa PCC7806, y, su producción de microcistina. Con este propósito, se determinó el crecimiento y la
concentración de microcistina intracelular en M. aeruginosa cuando ésta se encontraba en presencia de los fármacos y de
uno de los solventes orgánicos más comunes en nuestros ríos. El crecimiento fue estimado mediante la determinación de la
cantidad de clorofila a, la cual no presentó cambios apreciables en las condiciones ensayadas. Los cambios de expresión
del operon mcy se estudiaron a través del análisis del gen mcyD mediante RT-PCR semicuantitativa. La producción de
microcistina intracelular fue determinada mediante MicroCystest R⃝sin mostrarse cambios relevantes en comparación con las
células control. Se concluye que los contaminantes analizados en este estudio no tienen un efecto significativo en la producción
de microcistina, al menos, en los experimentos realizados en el laboratorio, en esta cepa, y con las dosis utilizadas.
Palabras clave: Microcistina-LR, contaminantes emergentes, mcyD.
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INTRODUCTION
The progress of society often causes changes in
the environment. In river basins, many human
activities that developed during the Industrial
Revolution, continue to reduce the river flow
and to cause influxes of many contaminants,
including nutrients from untreated water, inor-
ganic and organic fertilisers and industrial waste.
These changes primarily affect phytoplankton,
biofilms and bacteria, which are responsible
for water quality (Vitousek et al., 1997). For
decades, efforts have been focused on iden-
tifying toxic, persistent and bioaccumulative
chemical contaminants. Over 100 000 hazardous
substances have been registered by the Euro-
pean Union (Fuerhacker, 2007). Nonetheless,
the development of more accurate analytical
methods has permitted the detection of new
hazardous contaminants in water bodies; these
contaminants are called emerging contaminants.
Pharmaceutical compounds are causing greater
concern due to their high levels of production and
consumption, along with insufficient degradation
in wastewater treatment plants. Pharmaceuticals
are continuously introduced into the ecosystem;
thus, these contaminants do not have to persist
in the ecosystem to produce negative effects on
the environment (Hartmann et.al., 1998; Jones et
al., 2001; Petrovic et al., 2004; Arslan-Alaton &
Caglayan, 2006). Analgesics/anti-inflammatory
drugs such as ibuprofen and diclofenac, carba-
mazepine and β-blockers are among the most
commonly used medical prescriptions ( Petrovic
et al., 2005; Hernando et al., 2006). The project
AquaTerra has estimated that three tons of
pharmaceuticals per year are discharged into our
rivers (Jones et al., 2001; Gros et al., 2007). In
many cases, the consequences of the presence
of these pharmaceuticals in the environment
are not clear; in other cases, the risk is evident.
For example, diclofenac affects mammalian
kidneys; this drug has also been associated with
the disappearance of the white-backed vultures
in India and Pakistan (Fent et al., 2006). Fent
and colleges also observed that exposure to pro-
pranolol affects zooplankton (Fent et al., 2006).
Cyanobacteria are prokaryotes with high
morphological complexity and physiological
diversity. These organisms have an outstanding
capacity to adapt to a wide range of envi-
ronments and to survive in extreme or highly
degraded environments. Certain cyanobacterial
species can produce a broad range of bioactive
secondary metabolites called cyanotoxins that
are potentially toxic to eukaryotic organisms
(Carmichael et al., 2001; Codd et al., 2005). The
human pressures exerted on water resources,
in combination with climate change, promote
accelerated eutrophication of water bodies.
This process results in an increase in blooms,
particularly cyanobacterial blooms, which are
frequently toxic. A growing number of blooms
dominated by toxic cyanobacteria may result
in severe health and environmental problems.
The toxins produced by cyanobacteria are pri-
marily hepatotoxic and neurotoxic. Microcystis
aeruginosa frequently forms blooms, and micro-
cystin is the most common toxin produced by
these cyanobacteria. Microcystin is synthesised
in a mixed polyketide synthase/nonribosomal
peptide synthetase system called microcystin
synthetase (mcy operon), which is also involved
in tailoring and transporting microcystin. Tillett
and co-workers identified and sequenced the mcy
operon, which is a 55-kb sequence that consists
of ten open reading frames that are bidirectional
transcribed from a central 732-bp intergenic
region between mcyA and mcyD (Tillett et al.,
2000). Microcystin synthesis is an inducible
Table 1. Oligonucleotides that were used as primers in the semi-quantitative RT-PCR analyses. Oligonucleótidos utilizados como
cebadores en el análisis de RT-PCR semicuantitativa.
Primers Sequence 5′ → 3′ Length Tm (◦C)
R16S dir CAAGTCGAACGGGAATCT TC 20 47R16S rev CTCAAGTACCGTCAGAACTTC 21
mcyD dir GAGCATTAAGGGCTAAATCG 20 45
mcyD rev CTTGGTTGCTTCATCAACTC 20
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event that is thought to be controlled by many
environmental and nutritional factors. Two of
these factors are iron availability and the C:N
balance, which regulate the mcy operon through
two master transcriptional regulators, Fur (ferric
uptake regulator) and NtcA (Martin-Luna et al.,
2006; Kuniyoshi et al., 2011).
Currently, how environmental variables influ-
ence cyanotoxin production remains unknown.
Thus, monitoring and assessing the effects of
benzene and of some of the most used pharma-
ceuticals on microcystin production is of interest.
Paracetamol, atenolol, diclofenac and ibuprofen
are pharmaceuticals with high levels of produc-
tion and consumption. The concern is whether
the presence of those pharmaceuticals and of one
of the more common organic solvents, benzene,
which is found in our rivers, might cause an in-
crease in toxin synthesis. Because M. aerugi-
nosa PCC 7806 produces a high amount of mi-
crocystin per biomass, this cyanobacterium was
used to examine the effects of several emerging
contaminants and benzene on its toxicity.
MATERIALS AND METHODS
Growth conditions
The axenic strain M. aeruginosa PCC 7806,
which was provided by the Pasteur Culture Col-
lection (Paris, France), was used in this study.
Cells were grown under batch conditions in
BG11 media with 2 mM of NaNO3 and con-
tinuous agitation at 25 ◦C. The cyanobacteria
were grown with a light intensity of 40 µmol
of photons m−2 s−1; the light intensity was
measured using a Quantum Sensor photometer
(Skye Instruments, SKP 200). The cultures were
started with equal aliquots of 0.3 OD (600 nm),
and stress treatments were applied when the cells
reached the exponential growth phase (0.6-0.7
OD). Experiments were performed in 250 mL
Erlenmeyer flasks with continuous agitation.
Control flasks were maintained under the same
conditions as stressed flask. The following
concentrations of pharmaceuticals and benzene
were added to the cultures at exponential phase:
200 µg/L ibuprofen; 20 µg/L atenolol; 20 µg/L
diclofenac; 27 µg/L and 166 µg/L paracetamol;
and 50 µg/L and 100 µg/L benzene. All the
pharmaceuticals are water soluble at these con-
centrations. Aliquots were collected at four days
after the addition of the different compounds and
then compared with non-stressed cells.
Analytical methods and microcystin
quantification
Chlorophyll a concentrations were determined
spectrophotometrically by measuring the ab-
sorbance at 650 nm according to the procedure
described by Mackinney (Mackinney, 1941).
The pigment was extracted from 1 mL samples
using 80% methanol with stirring.
Aliquots (5 mL) were collected, centrifuged
for 5 min at 4000 rpm, and frozen at −20 ◦C
for microcystin determination. Total intracellu-
lar microcystin was determined from 4 extrac-
tions, which were performed using 1 mL of 80%
methanol, 0.1% trifluoroacetic acid (TFA), and
0.1% Tween. For each extraction, the samples
were stirred for 15 min and then centrifuged at
4000 g for 10 min. Next, the extracts were pooled
and quantified using a MicroCystest R⃝ kit (Zeu-
lab). Statistical analyses of all the data were per-
formed using Student’s test ( p < 0.05).
Sampling and RNA isolation
In total, 25 mL of each culture was harvested by
centrifugation at 4000 g for 4 min at 4 ◦C. The
manipulation was performed carefully to avoid
altering the RNA. Each cell pellet was suspended
in 600 µL of 50 mM Tris-HCl (pH 8), 100 mM
EDTA and 130 µL of chloroform and incubated
on ice for 3 min to eliminate external RNases.
After removing the buffer by centrifugation at
13 000 g for 5 min at 4 ◦C, the cell pellets were
frozen in liquid nitrogen and kept at −80 ◦C until
RNA isolation was achieved.
RNA was extracted using TRIzol (Invitro-
gen) and chloroform extractions according to
the manufacturer’s instructions. In the last ex-
traction, RNA was collected from the aqueous
layer and precipitated in isopropanol and liquid
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nitrogen. Then, the RNA pellet was washed
twice with 75% ethanol.
Reverse transcription (cDNA synthesis)
Total RNA was treated with 40 units of DNase I
(Pharmacia) to eliminate the DNA in the samples.
The digestions were incubated at 37 ◦C for 1 h
in a volume of 100 µL using a buffer containing
4 µL of 1 M Tris-HCl (pH 7.5) and 0.6 µL of 1 M
MgCl2 in DEPC-H2O. After digestion, the en-
zyme was inactivated by phenol acid:chloroform
extraction, and RNA was precipitated with absolute
ethanol. The result of the digestion was assessed by
PCR using primers targeting the16S rRNA gene.
RNA integrity was verified using a 1%
agarose gel, and the concentration was deter-
mined by measuring the absorbance at 260 nm
using a NanoVue (GE Healthcare).
A reverse transcriptase enzyme kit was used
for the reverse transcription reaction. In total,
1 µg of total RNA was diluted with annealing
buffer (10 mM Tris-HCl (pH 8), 1 mM EDTA,
and 150 mM KCl) and mixed with 150 ng of ran-
dom hexamer primers (Invitrogen Corp.) in a fi-
nal volume of 10 µL. The mixture was heated at
85 ◦C for 10 min and then incubated at 50 ◦C for
1 h. RNA was reverse transcribed using 200 U
of SuperScriptTM (Gibco BRL) in the presence of
2 µL of deoxyribonucleoside triphosphate mix-
ture (2.5 mM each one), 2 µL of dithiothreitol
(100 mM) and 4 µL of the 5x buffer, adjust-
ing with DEPC-H2O to reach a final volume of
20 µL. Then, the mixture was incubated at 47 ◦C
for 1 h and finally heated at 75 ◦C for 15 min.
RT-PCR analysis of gene expression
Semi-quantitative RT-PCR analyses were per-
formed with the obtained cDNA samples. 16S
rRNA (rrs) was used as the housekeeping gene,
and specific primer sets were designed to amplify
both the studied genes and the endogenous refer-
ence gene (Table 1). rrs was used to normalise
the possible variation in cDNA concentration as
described previously (González et al., 2010). The
exponential phase of the amplification was esti-
mated by measuring the amount of PCR products
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Figure 1. M. aeruginosa PCC 7806 growth in the pres-
ence of different drugs at their maximum concentrations found
in water bodies. The response was estimated using changes
in chlorophyll a concentrations. Panel A: Non-stressed cells
and ibuprofen (200 µg/L)-, atenolol (20 µg/L)- and diclofenac
(20 µg/L)-treated cells. Panel B: Non-stressed cells and parac-
etamol (27 µg/L and 166 µg/L)-treated cells. Panel C: Non-
stressed cells and benzene (50 µg/L and 100 µg/L)-treated cells.
*A significant decrease ( p<0.05) was observed with 100 µg/L
of benzene after two days of treatment. Curva de crecimiento
de Microcystis aeruginosa PCC7806 en presencia de diferentes
fármacos a la concentración maxima disuelta encontrada en
aguas. La respuesta fue analizada mediante variaciones de clo-
rofila a. Panel A: células control, células tratadas con ibupro-
feno 200 µg/l, atenolol 20 µg/l and diclofenac 20 µg/l. Panel
B: células control, células tratadas con paracetmol a las dos
concentraciones estudiadas: 27 µg/l y 166 µg/l. Panel C: célu-
las control, células tratadas con benceno a las dos concentra-
ciones estudiadas: 50 µg/l and 100 µg/l. *Descenso significa-
tivo (p<0.05) en el segundo día tras el tratamiento con 100 µg/l
de benceno.
after different numbers of cycles. That number
of cycles was utilised for gene normalisation.
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PCR-amplified DNA fragments were separated
by 1% agarose gel electrophoresis stained with
ethidium bromide and analysed using a Gel Doc
2000 Image Analyser (Bio-Rad).
RESULTS
Effects of benzene, paracetamol, ibuprofen,
atenolol, and diclofenac on M. aeruginosa
PCC7806 growth
The concentrations of emerging contaminants
used in this study were in the upper range
or moderately higher (10-20 times) than the
concentrations found in some Spanish rivers
according to the literature (Barceló & López,
2007; Gros et al., 2007). The concentration of
paracetamol in surface water has a wide range,
from 0.1 ng/L to 2.4 µg/L (Osorio et al. 2012).
Ibuprofen and diclofenac are the most concen-
trated anti-inflammatory drugs, with concentra-
tions up to the mg/L range (Osorio et al. 2012).
Atenolol contamination can reach values of ap-
proximately 0.5 mg/L. Figure 1 shows the chan-
ges in chlorophyll a concentrations when cells
were grown in the presence of the different
contaminants. Panel A shows the small changes
in cell growth that were observed in the presence
of ibuprofen, atenolol and diclofenac (Voltaren).
Panel B reflects the growth observed when
two doses of paracetamol were used; no differ-
ences in cell growth were observed between
the stressed cells and the control cells. Panel C
indicates changes in cell growth in the presence
of benzene.
Benzene is a well-known, volatile carcino-
gen that is one of the twenty chemical prod-
ucts with major production. The benzene con-
centrations studied, 50 µg/L and 100 µg/L, were
chosen based on levels under specific pollution
episodes described in the literature (Hedgecott &
Lewis, 1997; Fernández et al., 2013). However,
some industrial effluents, for instance, leachates
from dumpsites of an old lindane factory, can
reach considerably higher amounts, in the mg/L
range (Fernández et al., 2013). When M. aerugi-
nosa cells were exposed to benzene, their growth
was slightly affected during the early days and
was significant (Student’s test with p < 0.05) on
the 2nd day of treatment with 100 µg/L benzene.
However, after 4 days, M. aeruginosa recovered
and reached the same density as that of control
cells (Fig. 1C) most likely due to the high volatil-
ity of benzene. Microcystis growth curves for at
least 3 different samples were analysed; the re-
sults are shown in Figure 1.
Effects of benzene, paracetamol, ibuprofen,
atenolol, and diclofenac on mcyD expression
levels
The extracted total RNA was reverse transcribed,
and RT-PCR was performed with cDNA using
the rrs gene (16S) as the housekeeping gene.
Changes in mRNA levels after 4 days of exposure
are shown in Figure 2. The mcyD gene encodes
a polyketide synthase that is responsible for in-
corporating the Adda group, which is involved
in the toxicity of the molecule (Nishizawa et al.,
2000; Tillett et al., 2000). This gene is the first
gene that is transcribed and, therefore, is essen-
tial for microcystin synthesis. mcyD expression
was slightly induced in cells treated with 50 µg/L
diclofenac and benzene compared with that in
control cells (Fig. 2A). Nevertheless, mcyD ex-
pression decreased in cells grown in the presence
of 100 µg/L ibuprofen and benzene (Fig. 2A). In
the case of paracetamol, we collected aliquots
of cells treated with the highest concentration of
paracetamol (166 µg/L) for RNA reverse tran-
scription. When we analysed the gene expression
levels in the paracetamol-treated cells, we ob-
served an extreme decrease in transcription levels
compared with those of control cells (Fig. 2B).
Microcystin-LR content in treated
M. aeruginosa cells
The levels of Microcystin-LR and the minority
D-Aps3 MC-LR, which are the only two variants
found in this strain (Wiedner et al., 2003), were
measured using a MicroCystest R⃝ kit. This test
is based on phosphatase 2A inhibition. The re-
sults, which are expressed as total microcystin-
LR equivalents, are represented in Figure 3. The
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obtained results did not show significant changes
(Student’s test with p < 0.05) in microcystin le-
vels in cells treated with pharmaceuticals. The to-
tal microcystin content was slightly decreased in
ibuprofen- and Voltaren-treated cells, while the
microcystin content in atenolol-treated cells was
similar to non-treated cells. Both concentrations
of paracetamol showed slightly decreased micro-
cystin content versus control cells.
Figure 3C shows the level of microcystin
measured in benzene-treated cells. No significant
change ( p < 0.05) was observed. However, the
microcystin contents at both benzene concentra-
tions were slightly lower than control cells after
4 days.
DISCUSSION
In recent years, significant amounts of substances
that have gone unnoticed thus far have been de-
tected. For instance, the Ebro River was studied
during years within the framework of the Eu-
ropean project AquaTerra (Integrated modelling
of the river-sediment-soil-groundwater system).
Data from other fluvial systems indicated spe-
cific episodes of high levels of emerging contam-
inants (Hedgecott & Lewis, 1997; Jurado et al.,
2012; Osorio et al., 2012). Wastewater treatment
stations were unable to eliminate many of these
emerging contaminants; thus, these contaminants
flowed into the rivers. Approximately three tons
of drugs per year were discharged into the Ebro
River; the four pharmaceuticals used in this work
were among these drugs (Gros et al., 2007).
Some anti-inflammatory drugs employed in
this study, i.e., diclofenac and ibuprofen, are
ubiquitous in the affluent of every wastewater
treatment plant (EDARs) (Barceló & López,
2007; Gros et al., 2007). Other drugs, including
β-blockers such as atenolol represent a high per-
centage of the total contaminants in all EDARs.
In addition to wastewaters, atenolol is among the
compounds that represent more than 50% of the to-
tal load of the river (Fuerhacker, 2007). Some
studies have examined the effect of antibiotics
on cyanobacteria; sensitivity to antibiotics has
been reported (Holten-Lützhøft et al., 1999; Hal-
ling-Sørensen et al., 2000). Notably, the results
presented in this work may be influenced by
changes in the real concentration exposure. Ad-
ditionally, our work was performed under labo-
ratory conditions, eliminating the complexity of
natural ecosystems. Therefore, with the caution
of a laboratory study in a single strain, the results
obtained with the chosen concentrations of the
pharmaceuticals tested indicated that exposure
to these drugs does not significantly affect the
A) B)
4 days 4 days
mcyD mcyD
rrs rrs
C CA V I B(50 g/l)  B(100 g/l)µ µ P( g/l)166 µ
Figure 2. Changes in mcyD expression in M. aeruginosa PCC 7806 cells treated with drugs and benzene. mcyD expression was
analysed by semi-quantitative RT–PCR. The housekeeping gene rrs was used as a control. Determinations for each gene were
performed in the exponential phase of PCR. Panel A: mcyD expression in atenolol (A)-, Voltaren (V)-, ibuprofen (I)- and benzene (B)-
treated cells and in non-treated cells (C). Panel B: mcyD expression in paracetamol-treated cells (P) compared to that in control cells
(C). Cambios en la expression de mcyD en células de Microcystis aeruginosa PCC 7806 tratadas con los distintos fármacos y benceno.
La expresión fue estudiada mediante RT-PCR semicuantitativa. Se utilizó el gen rrs como gen de referencia. La determinación de
cada gen se llevó a cabo en la fase exponencial de la PCR. Panel A: expresión de mcyD en células control (C) y células tratadas
con atenolol (A), voltaren (V), ibuprofeno (I) y benceno (B). Panel B: expresión de mcyD en células control y células tratadas con
paracetamol (P).
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Figure 3. Intracellular microcystin content, which was deter-
mined as microcystin-LR equivalents, in stressed cells and in
control cells. Panel A: Non-treated cells, ibuprofen (200 µg/L)-,
atenolol (20 µg/L)- and Voltaren (20 µg/L)-treated cells. Panel
B: Non-treated cells and paracetamol-(27 µg/L and 166 µg/L)-
treated cells. Panel C: Non-treated cells and benzene (50 µg/L
and 100 µg/L)-treated cells. Cantidad de microcistina intracelu-
lar expresada en equivalentes de Microcistina-LR presente en
las células control y en las células tratadas. Panel A: célu-
las control, células tratadas con ibuprofeno 200 µg/l, atenolol
20 µg/l and diclofenac 20 µg/l. Panel B: células control, célu-
las tratadas con paracetamol a las dos concentraciones estu-
diadas: 27 µg/l y 166 µg/l. Panel C: células control, células
tratadas con benceno a las dos concentraciones estudiadas:
50 µg/l and 100 µg/l.
growth of M. aeruginosa PCC 7806 under these
conditions.
Although we observed a slight decrease in
cell growth with some of the treatments, no in-
crease in microcystin production was observed.
Figures 2 and 3 show that the observed changes
in transcriptional levels did not correlate with
microcystin-LR content. We observed a slight
reduction in the total amount of toxin in cells
treated with ibuprofen and diclofenac. Nonethe-
less, only ibuprofen lowered gene expression. In-
tracellular microcystin contents did not exhibit
appreciable changes when the cells were treated
with benzene; these results are consistent with
mcyD expression.
The most remarkable finding was that para-
cetamol treatment had a slight effect on the
growth of Microcystis and was accompanied by
an important reduction in mcyD transcription.
However, the analysis of the total microcystin
content in these cells indicated that a slightly
lower amount of toxin was synthesised in these
cells than that in control cells.
In summary, no significant changes in growth
and microcystin levels were detected in M. aerugi-
nosa treated with overdoses of ibuprofen, atenolol,
Voltaren, paracetamol and benzene compared with
amounts described in natural waters.
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